Predicting the treatment response of certolizumab for individual adult patients with rheumatoid arthritis: protocol for an individual participant data meta-analysis.
Yan LuoKonstantina ChalkouRyo YamadaSatoshi FunadaGeorgia SalantiToshi A FurukawaPublished in: Systematic reviews (2020)
PROSPERO registration number pending (ID#157595).